BlackRock Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8K | Hold |
2,670
| – | – | ﹤0.01% | 3519 |
|
|
2016
Q3 | $16K | Hold |
2,670
| – | – | ﹤0.01% | 3428 |
|
|
2016
Q2 | $8K | Sell |
2,670
-4,350
| -62% | -$13K | ﹤0.01% | 3561 |
|
|
2016
Q1 | $38K | Hold |
7,020
| – | – | ﹤0.01% | 3188 |
|
|
2015
Q4 | $83K | Sell |
7,020
-2,481
| -26% | -$29.3K | ﹤0.01% | 2954 |
|
|
2015
Q3 | $78K | Buy |
9,501
+394
| +4% | +$3.24K | ﹤0.01% | 3143 |
|
|
2015
Q2 | $127K | Buy |
9,107
+6,295
| +224% | +$87.8K | ﹤0.01% | 3029 |
|
|
2015
Q1 | $68K | Buy |
2,812
+271
| +11% | +$6.55K | ﹤0.01% | 3142 |
|
|
2014
Q4 | $42K | Buy |
2,541
+1,097
| +76% | +$18.1K | ﹤0.01% | 3277 |
|
|
2014
Q3 | $18K | Sell |
1,444
-31,666
| -96% | -$395K | ﹤0.01% | 3471 |
|
|
2014
Q2 | $747K | Sell |
33,110
-53,618
| -62% | -$1.21M | ﹤0.01% | 1672 |
|
|
2014
Q1 | $2.45M | Buy |
+86,728
| New | +$2.45M | ﹤0.01% | 1114 |
|